Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to $165000.0.

  • Usana Health Sciences' Exchange Rate Effect fell 9697.14% to $165000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year decrease of 17718.44%. This contributed to the annual value of -$6.2 million for FY2024, which is 14742.31% down from last year.
  • Usana Health Sciences' Exchange Rate Effect amounted to $165000.0 in Q3 2025, which was down 9697.14% from $2.3 million recorded in Q2 2025.
  • Usana Health Sciences' 5-year Exchange Rate Effect high stood at $5.4 million for Q3 2024, and its period low was -$9.2 million during Q4 2022.
  • In the last 5 years, Usana Health Sciences' Exchange Rate Effect had a median value of -$584000.0 in 2022 and averaged -$1.3 million.
  • In the last 5 years, Usana Health Sciences' Exchange Rate Effect skyrocketed by 77208.9% in 2022 and then crashed by 58215.19% in 2024.
  • Usana Health Sciences' Exchange Rate Effect (Quarter) stood at -$2.0 million in 2021, then soared by 300.05% to $3.9 million in 2022, then grew by 3.54% to $4.1 million in 2023, then crashed by 267.57% to -$6.8 million in 2024, then skyrocketed by 102.42% to $165000.0 in 2025.
  • Its Exchange Rate Effect stands at $165000.0 for Q3 2025, versus $2.3 million for Q2 2025 and $719000.0 for Q1 2025.